David Rimm, MD, PhD, shared the rationale behind developing an AI-driven tool for quantifying tumor-infiltrating lymphocytes in melanoma.
David Rimm, MD, PhD
Advertisement
Articles by David Rimm, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
T-DXd Improves Invasive DFS vs T-DM1 in HER2+ Early Breast Cancer Subgroup
2
FDA Advises Against BLA for Novel Vaccine Combo/Pembrolizumab in Melanoma
3
Moving Beyond Chemotherapy in Relapsed/Refractory ES-SCLC Treatment
4
TTFields After SRS Prolongs Intracranial Response in Brain Metastatic NSCLC
5
